Triple

T22041526
Position Surface form Disambiguated ID Type / Status
Subject Medicare Prescription Drug, Improvement, and Modernization Act of 2003 E544646 entity
Predicate alsoKnownAs P39 FINISHED
Object Medicare Prescription Drug Benefit law NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Medicare Prescription Drug Benefit law | Statement: [Medicare Prescription Drug, Improvement, and Modernization Act of 2003, alsoKnownAs, Medicare Prescription Drug Benefit law]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Medicare Prescription Drug Benefit law
Context triple: [Medicare Prescription Drug, Improvement, and Modernization Act of 2003, alsoKnownAs, Medicare Prescription Drug Benefit law]
  • A. Medicare Prescription Drug, Improvement, and Modernization Act of 2003 chosen
    The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is a major U.S. federal law that overhauled Medicare by adding outpatient prescription drug coverage and expanding private plan options for beneficiaries.
  • B. Prescription Drug User Fee Act of 1992
    The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
  • C. Prescription Drug Marketing Act
    The Prescription Drug Marketing Act is a U.S. federal law that regulates the distribution and marketing of prescription drugs to ensure their safety, effectiveness, and integrity within the pharmaceutical supply chain.
  • D. Medicaid Drug Rebate Program
    The Medicaid Drug Rebate Program is a U.S. federal initiative that requires drug manufacturers to provide rebates to state Medicaid programs in exchange for Medicaid coverage of their outpatient prescription drugs, helping control costs for the program.
  • E. Medicare Part D
    Medicare Part D is the U.S. federal program that provides outpatient prescription drug coverage to Medicare beneficiaries through private insurance plans.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e32445c8190ab97089b48a130bb completed April 16, 2026, 5:36 p.m.
NER Named-entity recognition batch_69f12829c1c081909edc7544242c9c7a completed April 28, 2026, 9:35 p.m.
Created at: April 16, 2026, 8:25 p.m.